Fri, Dec 26, 2014, 7:52 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Antares Pharma Inc. Message Board

  • imho_dyodd imho_dyodd Nov 10, 2013 12:24 PM Flag

    QS-T likely may not be approved. Testestorone treatment increases heart risk by 30% per new study

    QS-T likely may not be approved. Testestorone treatment increases heart risk by 30% per new study. just google . this was published on Nov 6 th

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This will not impact the QS_T studies at all. Investigators normally exclude adverse events that are not the result of the T treatment itself. The labeling may warn against its use by high risk patients, such as Viagra and all other drugs in existence. The FDA also does what is known as a risk/benefit analysis of healthy patients. If the benefits out way the risk on healthy patients, it will concern approval of the drug. For those who have other health issues, it will require a box warning.

    • Testestorone treatment increases heart risk by 30% per new study.

      So does Viagra, but #$%$ men pay that no attention either :)

    • [CHICAGO (AP) — Testosterone treatments may increase risks for heart attacks, strokes and death in older men with low hormone levels and other health problems, a big Veterans Affairs study suggests.

      The results raise concerns about the widely used testosterone gels, patches or injections that are heavily marketed for low sex drive, fatigue and purported anti-aging benefits, the authors and other doctors said.

      Men who used testosterone were 30 percent more likely to have a heart attack or stroke or to die during a three-year period than men with low hormone levels who didn't take the supplements. Hormone users and nonusers were in their early 60s on average, and most had other health problems including high blood pressure, unhealthy cholesterol and diabetes.

      The research doesn't prove that testosterone caused the heart attacks, strokes or death, but echoes a previous study in older men and should prompt doctors and patients to discuss potential risks and benefits of using the products, said study lead author Dr. Michael Ho, a cardiologist with the VA's Eastern Colorado Health System in Denver.]

    • QST is probably safer then other testosterone replacement therapies since you don't get the swings in your T-levels. In addition, the FDA is not issuing a new warning label for gels based on this new study so its really a non-issue for ATRS.

 
ATRS
2.70+0.05(+1.89%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.